4//SEC Filing
Mateus Fernando 4
Accession 0001415889-23-003056
CIK 0000001800other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 7:03 PM ET
Size
10.3 KB
Accession
0001415889-23-003056
Insider Transaction Report
Form 4
Mateus Fernando
Senior Vice President
Transactions
- Award
Common shares without par value
2023-02-17+10,560→ 25,063 total - Tax Payment
Common shares without par value
2023-02-21$106.74/sh−664$70,875→ 23,881 total - Award
Option (right to buy)
2023-02-17+41,648→ 41,648 totalExercise: $106.24From: 2024-02-17Exp: 2033-02-16→ Common Shares (41,648 underlying) - Tax Payment
Common shares without par value
2023-02-19$106.74/sh−518$55,291→ 24,545 total
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,882 on February 17, 2024, 13,883 on February 17, 2025, and 13,883 on February 17, 2026.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001895703
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 7:03 PM ET
- Size
- 10.3 KB